No association of malignant B-cell non-Hodgkin lymphomas with ipsilateral SARS-CoV-2 vaccination.

Luise Victoria ClaaßPatrick MayrLisa PascholdThomas WeberDenis TerzievBertram JehsRichard BrillJohannes DoberBruno MärklClaudia WickenhauserPiotr CzapiewskiMartin TrepelRainer ClausMascha Binder

Published in: Cancer medicine (2023)

Together, we found no evidence that the current SARS-CoV-2 vaccines could serve as a trigger for lymphomagenesis in the draining lymph node areas of the deltoid region used for vaccination.

Keyphrases

sars cov
lymph node
respiratory syndrome coronavirus
neoadjuvant chemotherapy
hodgkin lymphoma
radiation therapy
early stage